Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Antibody-based proteomics: fast-tracking molecular diagnostics in oncology.

Brennan DJ, O'Connor DP, Rexhepaj E, Ponten F, Gallagher WM.

Nat Rev Cancer. 2010 Sep;10(9):605-17. doi: 10.1038/nrc2902. Epub 2010 Aug 19. Review.

PMID:
20720569
2.

Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.

Findeisen P, Neumaier M.

Clin Chem Lab Med. 2009;47(6):666-84. doi: 10.1515/CCLM.2009.159. Review.

PMID:
19445650
3.

Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture.

Paul D, Kumar A, Gajbhiye A, Santra MK, Srikanth R.

Biomed Res Int. 2013;2013:783131. doi: 10.1155/2013/783131. Epub 2013 Mar 17. Review.

4.

Antibody arrays--an emerging tool in cancer proteomics.

Kopf E, Zharhary D.

Int J Biochem Cell Biol. 2007;39(7-8):1305-17. Epub 2007 May 13. Review.

PMID:
17600752
5.

Antibody microarrays as tools for biomarker discovery.

Sanchez-Carbayo M.

Methods Mol Biol. 2011;785:159-82. doi: 10.1007/978-1-61779-286-1_11. Review.

PMID:
21901599
6.

Proteomics in cancer research: Are we ready for clinical practice?

Maes E, Mertens I, Valkenborg D, Pauwels P, Rolfo C, Baggerman G.

Crit Rev Oncol Hematol. 2015 Dec;96(3):437-48. doi: 10.1016/j.critrevonc.2015.07.006. Epub 2015 Aug 12. Review.

PMID:
26277237
7.

Protein Array-based Approaches for Biomarker Discovery in Cancer.

Huang Y, Zhu H.

Genomics Proteomics Bioinformatics. 2017 Apr;15(2):73-81. doi: 10.1016/j.gpb.2017.03.001. Epub 2017 Apr 7. Review.

8.

Proteomics as a guiding tool for more effective personalized therapy.

Lee JM, Kohn EC.

Ann Oncol. 2010 Oct;21 Suppl 7:vii205-10. doi: 10.1093/annonc/mdq375. Review.

9.

The evolving role of mass spectrometry in cancer biomarker discovery.

Wang P, Whiteaker JR, Paulovich AG.

Cancer Biol Ther. 2009 Jun;8(12):1083-94. Epub 2009 Jun 6. Review.

10.

Antibody-Based Proteomics.

Wingren C.

Adv Exp Med Biol. 2016;926:163-179. Review.

PMID:
27686812
11.

Oncoproteomics: Trials and tribulations.

Zhou L, Li Q, Wang J, Huang C, Nice EC.

Proteomics Clin Appl. 2016 Apr;10(4):516-31. doi: 10.1002/prca.201500081. Epub 2015 Dec 9. Review.

PMID:
26518147
12.

Proteomic contributions to personalized cancer care.

Koomen JM, Haura EB, Bepler G, Sutphen R, Remily-Wood ER, Benson K, Hussein M, Hazlehurst LA, Yeatman TJ, Hildreth LT, Sellers TA, Jacobsen PB, Fenstermacher DA, Dalton WS.

Mol Cell Proteomics. 2008 Oct;7(10):1780-94. doi: 10.1074/mcp.R800002-MCP200. Epub 2008 Jul 29. Review.

13.

The road from discovery to clinical diagnostics: lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers.

Zhang Z, Chan DW.

Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):2995-9. doi: 10.1158/1055-9965.EPI-10-0580. Epub 2010 Oct 20.

14.

The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients.

Kelleher MT, Fruhwirth G, Patel G, Ofo E, Festy F, Barber PR, Ameer-Beg SM, Vojnovic B, Gillett C, Coolen A, Kéri G, Ellis PA, Ng T.

Target Oncol. 2009 Sep;4(3):235-52. doi: 10.1007/s11523-009-0116-y. Epub 2009 Sep 16. Review.

15.

Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.

de Wit M, Fijneman RJ, Verheul HM, Meijer GA, Jimenez CR.

Clin Biochem. 2013 Apr;46(6):466-79. doi: 10.1016/j.clinbiochem.2012.10.039. Epub 2012 Nov 13. Review.

PMID:
23159294
16.

Cancer Biomarkers Discovery and Validation: State of the Art, Problems and Future Perspectives.

Mordente A, Meucci E, Martorana GE, Silvestrini A.

Adv Exp Med Biol. 2015;867:9-26. doi: 10.1007/978-94-017-7215-0_2. Review.

PMID:
26530357
17.

Usage of cancer associated autoantibodies in the detection of disease.

Dudas SP, Chatterjee M, Tainsky MA.

Cancer Biomark. 2010;6(5-6):257-70. doi: 10.3233/CBM-2009-0138. Review.

18.

Proteomics in cancer.

Reymond MA, Schlegel W.

Adv Clin Chem. 2007;44:103-42. Review.

PMID:
17682341
19.

[Proteomics for biomarker development toward personalized medicine].

Kondo T.

Rinsho Byori. 2012 Jul;60(7):644-9. Japanese.

PMID:
22973724
20.

Supplemental Content

Support Center